Researchers have identified a new subtype of prostate cancer that occurs in about 7% of patients with advanced diseases. The subtype is characterised by loss of the gene CDK12. It was found to be a more common in metastatic prostate cancer compared to early stage tumours that had not spread, ... Read More »